✦ LIBER ✦
NE Chemcat to widen operations with catalysts developed inhouse
- Publisher
- Elsevier Science
- Year
- 2006
- Weight
- 44 KB
- Volume
- 2006
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
✦ Synopsis
4Q 2004), while revenue for 2005 was $2.7 bn (24% over $2.2 bn in 2004). R&D expenses were $138.186 M for 4Q 2005 ($107.428 M in 4Q 2004). For 2005, R&D expenses were $502.657 M ($391.802 M in 2004). Genzyme confirmed the revenue and earnings guidance for 2006 that it provided in Jan 2006.